DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden/Drucken
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln

18.12.2008 12:00

Senden

Wimm-Bill-Dann Foods OJSC Announces 25% Revenue Growth in First Nine Months of 2008

Wimm-Bill-Dann Foods zu myNews hinzufügen Was ist das?


Wimm-Bill-Dann Foods OJSC [NYSE: WBD] today announced its financial results for the third quarter and the first nine months ended September 30, 2008.

Highlights of the first nine months of 2008:

  • Strong double-digit revenue growth across all business segments
  • Group revenue increased 24.8% to US$2,194.1 million
  • Gross profit grew 22.2% to US$707.0 million
  • Operating income rose 15.1% to US$193.6 million
  • Net income increased 3.7% to US$109.6 million
  • EBITDA1 rose 23.3% to US$282.7 million
  • Operating cash flow grew 156.8% to US$168.5 million

"Despite a challenging operating environment, we achieved strong double-digit revenue and EBITDA growth in the third quarter and the nine months of 2008, which further testifies to the strength and resilience of the business and our focus on executing our strategy,” said Tony Maher, Wimm-Bill-Dann’s Chief Executive Officer.

"We continue to face significant headwinds created by a decline in consumer confidence in Russia and CIS, slower GDP growth, and unprecedented global financial turmoil. Nevertheless, our balance sheet is strong, our liquidity is excellent, and we are comfortable with our debt position, including a bond of approximately $185 million that we will pay down in March of 2009 if required. We may choose to refinance the debt if financing is available at attractive rates, but as of today, we are planning to repay those obligations with internal funds. We have a strong cash balance of $137 million as of the end of the third quarter and we continue to generate significant cash flow from operations, totalling $168 million in the first nine months of the year.”

"All of our business segments continue to post strong results, with group revenue growing 25% for the first nine months of 2008 on a year-over-year basis to nearly $2.2 billion. This growth has been purely organic. Our dairy segment delivered sales of $1.6 billion in the first nine months of 2008, up nearly 23% year-over-year. Our beverage business achieved sales growth of nearly 20% to $372.5 million through the first nine months of the year. And our baby food sales for the first nine months of 2008 grew 61% over same period in 2007 to $191.6 million.”

"Our gross profit for the first nine months of 2008 was $707 million, up 22% from the same period a year ago. This improvement was across all three business segments. EBITDA also continued to show solid improvement. For the first nine months of 2008, EBITDA was $282.7 million, up 23.3% from the first nine months of 2007.

"In conclusion, I would like to add that we remain confident in our financial strength, our ability to execute, and our strategy for sustained profitability. Over the last several years, we have put in place a strong foundation, which, combined with the very nature of our business, will see us emerge even stronger from this uncertain period”

Key Financial Indicators for the First Nine Months and 3Q 2008 vs. 2007

         
9M2008   9M2007   Change   3Q2008   3Q2007   Change
US$ ‘mln US$ ‘mln US$ ‘mln US$ ‘mln
 
Sales 2,194.1 1,758.3 24.8 % 702.1 610.5 15.0 %
Dairy 1,630.0 1,328.7 22.7 % 524.6 470.3 11.5 %
Beverages 372.5 310.6 19.9 % 113.5 98.5 15.2 %

Baby Food

191.6 119.0 61.0 % 64.0 41.7 53.5 %
Gross profit 707.0 578.4 22.2 % 236.6 200.6 18.0 %
Selling and distribution expenses 365.7 281.7 29.8 % 124.6 95.8 30.1 %
General and administrative expenses 136.5 129.5 5.4 % 39.6 43.2 (8.4 %)
Operating income 193.6 168.3 15.1 % 67.6 59.9 12.9 %
Financial expenses, net 36.5 15.4 137.1 % 24.7 2.9 759.7 %
Net income 109.6 105.6 3.7 % 31.0 39.8 (22.2 %)
EBITDA 282.7 229.4 23.3 % 98.9 82.2 20.3 %
CAPEX excluding acquisitions 158.9   127.7   24.4 %   47.7   58.6   (18.6 %)

Dairy

Sales in the Dairy Segment increased 22.7% to US$1,630.0 million in the first nine months of 2008 from US$1,328.7 million in the same period of 2007. The growth was organic, driven primarily by pricing and offset slightly by volume decline. The average Dollar selling price rose 33.0% to US$1.40 per kg in the first nine months of 2008 from US$1.05 per kg in the same period of 2007 driven primarily by average ruble price growth and exchange rate effect. Our raw milk purchasing price grew 35.7% year-on-year in ruble terms (46.2% in US dollar terms) in the first nine months of 2008. The gross margin in the Dairy Segment decreased to 29.1% in the first nine months of 2008 from 30.1% in the first nine months of 2007. Despite continued raw milk cost pressure, the gross margin in the Dairy segment improved slightly to 30.8% in the third quarter of 2008 from 30.5% in the third quarter 2007 and also improved sequentially from 30.1% in the second quarter of 2008.

Beverages

Sales in the Beverages Segment increased 19.9% to US$372.5 million in the first nine months of 2008 from US$310.6 million during the same period last year, driven mainly by a healthy balance of price, volume and mix. The average dollar selling price increased 14.8% to US$0.95 per liter in the first nine months of 2008 from US$0.83 per liter in the first nine months of 2007. The gross margin in the Beverages Segment decreased to 38.6% in the first nine months of 2008 from 40.4% in the same period last year, due to concentrate cost pressure. The gross margin in Beverages increased slightly to 40.0% in the third quarter of 2008 from 39.6% in the third quarter last year.

Baby Food

Sales in the Baby Food Segment increased 61.0% to US$191.6 million in the first nine months of 2008 from US$119.0 million in the same period last year, driven by a healthy balance of volume and price. The average selling price rose 27.4% to US$2.37 per kg in the first nine months of 2008 from US$1.86 per kg in the first nine months of 2007. The gross margin in the Baby Food Segment increased to 46.6% in the first nine months of 2008 from 44.4% in the first nine months of 2007.

Key Cost Elements

In the first nine months of 2008, selling and distribution expenses increased 29.8% to US$365.7 million. Selling and distribution expenses, as a percentage of sales, stood at 16.7% in the first nine months of 2008 compared to 16.0% in the same period last year. General and administrative expenses increased 5.4% to US$136.5 million in the first nine months of 2008. General and administrative expenses, as a percentage of sales, declined to 6.2% in the first nine months of 2008 from 7.4% in the same period last year.

Operating profit increased 15.1% to US$193.6 million in the first nine months of 2008. EBITDA grew 23.3% to US$282.7 million.

In the first nine months of 2008, financial expenses grew to US$36.5 million from US$15.4 million in the same period of 2007. This was mainly a result of a currency revaluation loss of US$3.9 million in the first nine months of 2008 against currency revaluation gain in 2007 of US$14.0 million. Currency revaluation loss amounted to US$ 15.1 million in the third quarter of 2008 compared to currency revaluation gain in the third quarter of 2007 of US$8.4 million. Currency revaluation loss was incurred in the third quarter as a result of the weakening of the ruble against the dollar, impacting mainly US$250 million syndicated loan taken out in the second quarter of 2008. Currency revaluation loss is not a cash item.

Our effective tax rate decreased to 28.5% in the first nine months of 2008 from 29.3% in the same period of 2007.

Net Income

Net income increased 3.7% to US$109.6 million in the first nine months of 2008 from US$105.6 million in the first nine months of 2007. Underlying net income excluding foreign currency revaluation effect and adjusted for respective tax amount increased in the third quarter of 2008 by 23.7% year-on-year to $41.9 million, and by 17.4% year-on-year in the first nine months of 2008 to $112.4 million.

Attachment A

Reconciliation of EBITDA and EBITDA margin to US GAAP Net Income

EBITDA is a non-U.S. GAAP financial measure. The following table presents reconciliation of EBITDA to net income (and EBITDA margin to net income as a percentage of sales), the most directly comparable U.S. GAAP financial measure.

  9 months ended   9 months ended
September 30, 2008   September 30, 2007
US$ ‘mln   % of sales   US$ ‘mln   % of sales
 
Net income 109.6 5.0 % 105.6 6.0 %
Add: Depreciation and amortization 89.1 4.1 % 61.1 3.5 %
Add: Income tax expense 44.8 2.0 % 44.7 2.5 %
Add: Interest expense 35.2 1.6 % 29.5 1.7 %
Less: Interest income (4.3 ) (0.2 %) (2.3 ) (0.1 %)
Less: Currency remeasurement (gains)/losses, net 3.9 0.2 % (14.0 ) (0.8 %)
Add: Bank charges 2.0 (0.1 %) 2.1 (0.1 %)
Add: Minority interest 2.7 (0.1 %) 2.5 (0.1 %)
Add: Other (gains)/losses (0.3 ) (0.01 %) 0.1 0.004 %
 
EBITDA 282.7 12.9 % 229.4 13.0 %

EBITDA represents net income before interest, income taxes and depreciation and amortization, adjusted for interest income, currency remeasurement gains, bank charges and other financial expenses and minority interest. EBITDA margin is EBITDA expressed as a percentage of sales.

We present EBITDA because we consider it an important supplemental measure of our operating performance. In particular, we believe EBITDA provides useful information to securities analysts, investors and other interested parties because it is used in the "debt to EBITDA” debt incurrence financial measurement in certain of our financing arrangements.

EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as substitute for analysis of our operating results as reported under U.S. GAAP. Moreover, other companies in our industry may calculate EBITDA differently or may use it for different purposes than we do, limiting its usefulness as a comparative measure.

EBITDA also should not be considered as an alternative to cash flow from operating activities or as a measure of our liquidity. In particular, EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business.

Condensed Consolidated Balance Sheets

(Amounts in thousands of U.S. dollars, except share data)

   
September 30,

2008

 

December 31,

2007*

Unaudited
ASSETS
Current assets:
Cash and cash equivalents 137,145 33,452
Trade receivables, net 154,116 157,608
Inventory 312,878 261,254
Taxes receivable 64,552 65,689
Advances paid 36,375 43,924
Deferred tax asset 22,619 17,479
Other current assets   14,492     13,252
Total current assets 742,177 592,658
 
Non-current assets:
Property, plant and equipment, net 803,641 767,654
Intangible assets 39,000 34,015
Goodwill 124,737 129,391
Deferred tax asset – long-term portion 1,061 2,947
Other non-current assets   9,550     6,437
Total non-current assets   977,989     940,444
Total assets $ 1,720,166   $ 1,533,102
 

* Balance sheet as of December 31, 2007 presented herein has been derived from the audited financial statement at that date.

Condensed Consolidated Balance Sheets

(Amounts in thousands of U.S. dollars, except share data)

   

September 30,

2008

 

December 31,

2007*

Unaudited
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Trade accounts payable 142,561 130,729
Advances received 10,928 13,626
Short-term debt 244,722 405,274
Taxes payable 16,510 14,351
Accrued liabilities 36,697 51,877
Other payables   52,080     40,349
Total current liabilities 503,498 656,206
 
Long-term liabilities:
Long-term debt 399,055 140,553
Other long-term payables 8,415 18,346
Deferred taxes – long-term portion   35,015     31,011
Total long-term liabilities   442,485     189,910
 
Total liabilities   945,983     846,116
 
Minority interest 14,893 13,862
 
Shareholders’ equity:
Common stock: 44,000,000 shares authorized, issued and outstanding with a par value of 20 Russian rubles at September 30, 2008 and December 31, 2007

 

29,908

 

29,908

Share premium account 164,132 164,132
Accumulated other comprehensive income:
Currency translation adjustment 86,765 110,171
Retained earnings   478,485     368,913
Total shareholders’ equity   759,290     673,124
 
Total liabilities and shareholders’ equity $ 1,720,166   $ 1,533,102
 

* Balance sheet as of December 31, 2007 presented herein has been derived from the audited financial statement at that date.

Condensed Consolidated Statements of Operations and

Comprehensive Income (unaudited)

(Amounts in thousands of U.S. dollars, except share and per share data)

 

Nine months ended

September 30,

  2008       2007  
 
Sales $ 2,194,132 $ 1,758,316
 
Cost of sales   (1,487,084 )     (1,179,894 )
 
Gross profit 707,048 578,422
 
Selling and distribution expenses (365,745 ) (281,704 )
General and administrative expenses (136,455 ) (129,495 )
Other operating income (expenses) net   (11,221 )     1,025  
 
Operating income 193,627 168,248
 
Financial income and expenses, net   (36,513 )     (15,401 )
 
Income before provision for income taxes

and minority interest

157,114 152,847
 
Provision for income taxes (44,830 ) (44,712 )
 
Minority interest   (2,712 )     (2,514 )
 
Net income $ 109,572     $ 105,621  
 
Other comprehensive income
Currency translation adjustment   (23,406 )     30,744  
 
Comprehensive income $ 86,166     $ 136,365  
 
Net income per share - basic and diluted $ 2.49     $ 2.40  
 
Weighted average number of shares outstanding 44,000,000 44,000,000

Condensed Consolidated Statements of Cash Flows (unaudited)

(Amounts in thousands of U.S. dollars)

 
Nine months ended
September 30,  
  2008       2007  
Cash flows from operating activities:  
Net income $ 109,572 $ 105,621
Adjustments to reconcile net income to net cash provided by operating activities 105,235 54,685
Changes in operating assets and liabilities   (46,350 )  

(94,713

)*

Total cash provided by operating activities   168,457       65,593  
 
Cash flows from investing activities:
Cash paid for acquisition of subsidiaries, net of cash acquired (700 ) (21,005 )
Cash paid for property, plant and equipment (155,313 ) (108,207 )
Cash invested in short-term bank deposits and other current assets - 6,718
Other investing activities   2,140       3,551  
Net cash used in investing activities   (153,873 )     (118,943 )
 
Cash flows from financing activities:
Proceeds from bonds and notes payable, net of debt issuance costs 207,476 151,466
Short-term loans and notes, net (60,542 ) (86,177 )
Repayment of long-term loans and notes (307,182 ) (3,621 )
Proceeds from long-term loans, net of debt issuance costs 268,970 7,692
Repayment of long-term payables (11,256 ) (15,691 )
Dividends paid   (118 )  

(5,420)

*

Total cash provided by financing activities   97,348       48,249  
 
Impact of exchange rate differences on cash and cash equivalents   (8,239 )     2,045  
Net change in cash and cash equivalents 103,693 (3,056 )
Cash and cash equivalents, at beginning of period   33,452       40,310  
Cash and cash equivalents, at the end of period $ 137,145     $ 37,254  
 

* Personal income taxes for dividends paid were re-classified in the cash flows from operating to financing activities. For comparative information, dividends paid and related taxes for the first nine months of 2007 have been adjusted, to conform to the presentation of the current period.

Some of the information contained in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of Wimm-Bill-Dann Foods OJSC, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to conform them to actual results. We refer you to the documents Wimm-Bill-Dann Foods OJSC files from time to time with the U.S. Securities and Exchange Commission, specifically, the Company's most recent Form 20-F. These documents contain and identify important factors, including those contained in the section captioned "Risk Factors" in our Form 20-F, that could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, potential fluctuations in quarterly results, and risks associated with our competitive environment, acquisition strategy, ability to develop new products or maintain market share, brand and company image, operating in Russia, volatility of stock price, financial risk management, and future growth.

NOTES TO EDITORS

Wimm-Bill-Dann Foods OJSC was founded in 1992 and is the largest manufacturer of dairy products and a leading producer of juices and beverages in Russia and the CIS. The company produces dairy products (main brands include: Domik v Derevne, Neo, 2Bio, 33 Korovy, Chudo and more), juices (J7, Lubimy Sad, 100% Gold), Essentuki mineral water and Agusha baby food. The company has 37 manufacturing facilities in Russia, Ukraine, Kyrgyzstan, Uzbekistan and Georgia with over 18,000 employees. In 2005, Wimm-Bill-Dann became the first Russian dairy producer to receive approval from the European Commission to export its products into the European Union.

In 2008, Standard & Poor's Governance Services assigned on WBD its governance, accountability, management, metrics, and analysis (GAMMA) score "GAMMA- 7+”. The score reflects the effective work of the Board of Directors and, in particular, the real influence of independent directors in the decision-making process and the adherence of the controlling shareholders to the highest standards of corporate governance.

1 Note: See Attachment A for definitions of EBITDA and EBITDA margin and reconciliations to net income.

Kommentare zu diesem Artikel

Geben Sie jetzt einen Kommentar zu diesem Artikel ab.
 Kommentar hinzufügen 
  • Relevant
  • Alle
  • vom Unternehmen
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
  • Alle
  • Buy
  • Hold
  • Sell
14.01.09Wimm-Bill-Dann Produkty kaufenEmerging Markets Investor
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Wimm-Bill-Dann Foods OJSC (ADRS) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

AKTIEN IN DIESEM ARTIKEL

ANZEIGE

Meistgelesene Wimm-Bill-Dann Foods News 1M

Keine Nachrichten gefunden.

Wimm-Bill-Dann Foods Peer Group News

Keine Nachrichten gefunden.

ANZEIGE

Was halten Sie von nutzergenerierten Chartanalysen auf finanzen.net?
Ich würde liebend gerne mein Wissen über Chartanalyse dem Publikum von finanzen.net zur Verfügung stellen.
Ich kenne mich bei Chartanalyse nicht so gut aus, halte nutzergenerierte Chartanalysen aber für einen echten Mehrwert.
Ich halte nichts von den Methoden der Chartanalyse und habe deshalb auch kein Interesse an nutzergenerierten Analysen.
 Abstimmen